US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharvaris N.V.

34.54

-0.3950-1.13%

Volume:131.41K

Turnover:4.55M

Market Cap:2.41B

PE:-11.53

High:35.97

Open:35.05

Low:34.16

Close:34.93

52wk High:38.13

52wk Low:20.65

Shares:69.86M

Float Shares:43.70M

Volume Ratio:0.43

T/O Rate:0.30%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.9943

EPS(LYR):-3.4871

ROE:-70.46%

ROA:-42.32%

PB:6.92

PE(LYR):-9.90

Loading ...

Overview Company News Filings

Pharvaris Says FDA Accepts NDA for Deucrictibant in Hereditary Angioedema Attacks

Pharvaris Nv - FDA Sets Pdufa Action Date for Deucrictibant Ir Nda as April 23, 2027

THOMSON REUTERS

Pharvaris Announces FDA Acceptance of New Drug Application for Deucrictibant Ir for On-demand Treatment of Hereditary Angioedema Attacks

THOMSON REUTERS

Pharvaris Chief Early Development Anne Lesage Disposes of Common Shares Worth $2,661,782.82

Cantor Fitzgerald Reaffirms Their Buy Rating on Pharvaris (PHVS)

Pharvaris Chief Medical Officer Lu Peng Disposes of 29,700 Common Shares for $1.02 Million

Pharvaris Shareholders Approve 2025 Accounts and Renew Board Authorities at 2026 AGM

Pharvaris Shareholders Adopt Dutch Statutory Annual Accounts for Fy2025

Pharvaris is Maintained at Overweight by Morgan Stanley

Pharvaris price target raised to $46 from $41 at Morgan Stanley

Pharvaris CMO Lu Peng disposes of 300 shares worth $10,200

Pharvaris (PHVS) Is Up 6.0% After Strong Phase 3 Oral HAE Data With Novel Endpoint Introduction

Simply Wall St.

Analysts Are Bullish on Top Healthcare Stocks: Crinetics Pharmaceuticals (CRNX), Pharvaris (PHVS)

Pharvaris says Phase 3 RAPIDe-3 trial shows oral deucrictibant cuts median HAE symptom relief time to 1.28 hours

Pharvaris publishes patient-reported outcomes presentation on clinical evidence in HAE trials

Pharvaris announces annual shareholder meeting

A Look At Pharvaris (PHVS) Valuation As Deucrictibant Data Advances Toward Key EAACI 2026 Catalyst

Simply Wall St.

The Bull Case For Pharvaris (PHVS) Could Change Following New Deucrictibant Phase 3 Data Disclosures

Simply Wall St.

Pharvaris to present Phase 3 RAPIDe-3 end-of-progression data for oral deucrictibant in hereditary angioedema at EAACI 2026

Pharvaris Principal Accounting Officer Anna Nijdam disposes of common shares worth $224,207.69

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/PHVS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PHVS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHVS\",,,,,undefined,":{"symbol":"PHVS","market":"US","secType":"STK","nameCN":"Pharvaris N.V.","latestPrice":34.535,"timestamp":1788369197413,"preClose":34.93,"halted":0,"volume":131407,"delay":0,"changeRate":-0.011308330947609595,"floatShares":43698700,"shares":69863685,"eps":-2.994346,"marketStatus":"Trading","change":-0.395,"latestTime":"09-02 13:13:26 EDT","open":35.05,"high":35.97,"low":34.16,"amount":4546647.377145001,"amplitude":0.051818,"askPrice":34.59,"askSize":20,"bidPrice":34.46,"bidSize":67,"shortable":3,"etf":0,"ttmEps":-2.994346,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":34.93,"preHourTrading":{"tag":"盘前","latestPrice":34.92,"preClose":34.93,"latestTime":"09:28 EDT","volume":149,"amount":5169.04244,"timestamp":1788355680063,"change":-0.01,"changeRate":-0.000286,"amplitude":0.029559},"postHourTrading":{"tag":"盘后","latestPrice":34.93,"preClose":34.93,"latestTime":"19:30 EDT","volume":4137,"amount":144505.41,"timestamp":1788305405826,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.432499,"impliedVol":1.3139,"impliedVolPercentile":0.9535},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHVS\",,,,,undefined,":{"symbol":"PHVS","floatShares":43698700,"roa":"-42.32%","roe":"-70.46%","lyrEps":-3.487143,"volumeRatio":0.432499,"shares":69863685,"dividePrice":0,"high":35.97,"amplitude":0.051818,"preClose":34.93,"low":34.16,"week52Low":20.65,"pbRate":"6.92","week52High":38.13,"institutionHeld":0,"latestPrice":34.535,"committee":0.54023,"eps":-2.994346,"divideRate":0,"volume":131407,"delay":0,"ttmEps":-2.994346,"open":35.05,"prevYearClose":27.75,"prevWeekClose":35.32,"prevMonthClose":34.61,"prevQuarterClose":34.58,"fiveDayClose":37,"twentyDayClose":33.42,"sixtyDayClose":31.59},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PHVS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"PHVS","fiscalQuarterEnding":"2026/06","expectedEps":-0.74,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"pre","actualEps":-0.81},{"market":"US","date":"2026-05-12","symbol":"PHVS","fiscalQuarterEnding":"2026/03","expectedEps":-0.76,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.7},{"market":"US","date":"2026-04-02","symbol":"PHVS","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1775102400000,"reportTimeType":"pre","actualEps":-0.84},{"market":"US","date":"2025-11-12","symbol":"PHVS","fiscalQuarterEnding":"2025/09","expectedEps":-0.78,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.7},{"market":"US","date":"2025-08-12","symbol":"PHVS","fiscalQuarterEnding":"2025/06","expectedEps":-0.87,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.94}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PHVS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PHVS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4667,"buy":0.4667,"hold":0.0667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4667,"analysts":15,"updateTime":1784174400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PHVS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PHVS","date":"2026-09-01","current":-11.533403,"percent":0.176664,"low":-16.528573,"twenty":-12.094187,"median":-8.622235,"eighty":-5.917471,"high":-1.271834,"avg":-8.826596,"sd":3.16724,"marketCap":2429777952},"quantilePoints":[{"date":"2021-09-03","current":-13.869765,"twenty":-41.690069,"median":-21.159134,"eighty":-14.206363,"marketCap":629774552},{"date":"2021-09-10","current":-14.483783,"twenty":-41.636401,"median":-21.097683,"eighty":-14.200739,"marketCap":654620997},{"date":"2021-09-17","current":-13.408551,"twenty":-41.415194,"median":-19.619941,"eighty":-14.095163,"marketCap":601399913},{"date":"2021-09-24","current":-13.735189,"twenty":-41.105195,"median":-19.412718,"eighty":-13.917369,"marketCap":614535400},{"date":"2021-10-01","current":-13.275187,"twenty":-41.073352,"median":-19.361573,"eighty":-13.752501,"marketCap":588032525},{"date":"2021-10-08","current":-11.567624,"twenty":-40.951984,"median":-19.206349,"eighty":-13.609193,"marketCap":511505475},{"date":"2021-10-15","current":-11.808567,"twenty":-40.76486,"median":-19.158657,"eighty":-13.358075,"marketCap":523431769},{"date":"2021-10-22","current":-11.367098,"twenty":-40.543106,"median":-18.996962,"eighty":-13.26419,"marketCap":505211043},{"date":"2021-10-29","current":-13.069107,"twenty":-40.31092,"median":-18.615071,"eighty":-13.235325,"marketCap":577431375},{"date":"2021-11-05","current":-11.318661,"twenty":-40.118706,"median":-18.174436,"eighty":-12.989342,"marketCap":499744825},{"date":"2021-11-12","current":-12.526544,"twenty":-39.882961,"median":-18.037659,"eighty":-12.809718,"marketCap":547946928},{"date":"2021-11-19","current":-11.924212,"twenty":-39.73926,"median":-17.467833,"eighty":-12.433857,"marketCap":515812193},{"date":"2021-11-26","current":-10.362749,"twenty":-39.575288,"median":-16.707882,"eighty":-12.294384,"marketCap":448064220},{"date":"2021-12-03","current":-11.26034,"twenty":-38.958466,"median":-15.822297,"eighty":-12.166304,"marketCap":485665173},{"date":"2021-12-10","current":-11.449501,"twenty":-38.90261,"median":-15.106412,"eighty":-12.085176,"marketCap":494941179},{"date":"2021-12-17","current":-11.918983,"twenty":-38.786622,"median":-14.824901,"eighty":-12.032102,"marketCap":513493191},{"date":"2021-12-23","current":-12.067526,"twenty":-38.613439,"median":-14.809703,"eighty":-12.04158,"marketCap":521775339},{"date":"2021-12-31","current":-10.970608,"twenty":-38.556139,"median":-14.6624,"eighty":-12.029733,"marketCap":476720453},{"date":"2022-01-07","current":-14.755715,"twenty":-38.260176,"median":-14.556631,"eighty":-12.04158,"marketCap":639381844},{"date":"2022-01-14","current":-13.648303,"twenty":-37.900499,"median":-14.301086,"eighty":-12.059144,"marketCap":595652102},{"date":"2022-01-21","current":-13.462107,"twenty":-37.887735,"median":-14.301086,"eighty":-12.06585,"marketCap":583394522},{"date":"2022-01-28","current":-13.205088,"twenty":-37.172324,"median":-14.201073,"eighty":-12.067932,"marketCap":563186081},{"date":"2022-02-04","current":-13.024782,"twenty":-36.626254,"median":-14.120681,"eighty":-12.079807,"marketCap":569480513},{"date":"2022-02-11","current":-13.759795,"twenty":-36.368387,"median":-14.065459,"eighty":-12.092451,"marketCap":599627533},{"date":"2022-02-18","current":-13.388638,"twenty":-36.150333,"median":-14.023379,"eighty":-12.098608,"marketCap":579750377},{"date":"2022-02-25","current":-13.305926,"twenty":-35.845851,"median":-13.954525,"eighty":-12.116084,"marketCap":572793372},{"date":"2022-03-04","current":-14.115965,"twenty":-35.670778,"median":-13.938377,"eighty":-12.137788,"marketCap":588695097},{"date":"2022-03-11","current":-13.463028,"twenty":-34.421493,"median":-13.892451,"eighty":-12.149516,"marketCap":563186081},{"date":"2022-03-18","current":-14.218002,"twenty":-29.632768,"median":-13.881977,"eighty":-12.157248,"marketCap":600952677},{"date":"2022-03-25","current":-13.943073,"twenty":-26.658074,"median":-13.883771,"eighty":-12.178203,"marketCap":585382238},{"date":"2022-04-01","current":-12.747151,"twenty":-26.362243,"median":-13.880091,"eighty":-12.194172,"marketCap":601209361},{"date":"2022-04-08","current":-13.160374,"twenty":-26.219887,"median":-13.869765,"eighty":-12.198767,"marketCap":611652204},{"date":"2022-04-14","current":-12.64181,"twenty":-26.010325,"median":-13.786628,"eighty":-12.200601,"marketCap":583804624},{"date":"2022-04-22","current":-12.23556,"twenty":-25.770465,"median":-13.764494,"eighty":-12.203958,"marketCap":563581977},{"date":"2022-04-29","current":-12.580911,"twenty":-25.660418,"median":-13.730786,"eighty":-12.217679,"marketCap":566542439},{"date":"2022-05-06","current":-12.310085,"twenty":-25.093495,"median":-13.707219,"eighty":-12.233824,"marketCap":557283119},{"date":"2022-05-13","current":-10.422165,"twenty":-24.148325,"median":-13.655613,"eighty":-12.198139,"marketCap":571878572},{"date":"2022-05-20","current":-10.134271,"twenty":-23.650401,"median":-13.608097,"eighty":-12.152353,"marketCap":563590477},{"date":"2022-05-27","current":-10.266885,"twenty":-23.509475,"median":-13.570194,"eighty":-12.096742,"marketCap":579835143},{"date":"2022-06-03","current":-10.984203,"twenty":-23.463638,"median":-13.4682,"eighty":-12.07039,"marketCap":620612572},{"date":"2022-06-10","current":-12.843347,"twenty":-23.155882,"median":-13.459721,"eighty":-12.067627,"marketCap":712444667},{"date":"2022-06-17","current":-16.528573,"twenty":-22.410251,"median":-13.457335,"eighty":-12.07039,"marketCap":911690477},{"date":"2022-06-24","current":-12.484354,"twenty":-22.307498,"median":-13.442896,"eighty":-12.079819,"marketCap":694210858},{"date":"2022-07-01","current":-14.299351,"twenty":-21.874535,"median":-13.402807,"eighty":-12.068033,"marketCap":784053810},{"date":"2022-07-08","current":-14.094213,"twenty":-21.750061,"median":-13.450115,"eighty":-12.077462,"marketCap":756209125},{"date":"2022-07-15","current":-14.396825,"twenty":-21.331431,"median":-13.463028,"eighty":-12.082165,"marketCap":765820001},{"date":"2022-07-22","current":-13.29424,"twenty":-21.174218,"median":-13.473474,"eighty":-12.092451,"marketCap":716422953},{"date":"2022-07-29","current":-13.469033,"twenty":-21.125909,"median":-13.4682,"eighty":-12.098608,"marketCap":724213762},{"date":"2022-08-05","current":-11.76507,"twenty":-21.101667,"median":-13.459721,"eighty":-12.082165,"marketCap":629895239},{"date":"2022-08-12","current":-10.43948,"twenty":-20.186916,"median":-13.408551,"eighty":-12.055631,"marketCap":564253524},{"date":"2022-08-19","current":-11.581834,"twenty":-19.826532,"median":-13.395996,"eighty":-12.028713,"marketCap":612987524},{"date":"2022-08-26","current":-5.820227,"twenty":-19.515891,"median":-13.372919,"eighty":-11.990749,"marketCap":306659524},{"date":"2022-09-02","current":-5.892736,"twenty":-19.429171,"median":-13.356682,"eighty":-11.943475,"marketCap":311632381},{"date":"2022-09-09","current":-5.834763,"twenty":-19.417564,"median":-13.345814,"eighty":-11.915113,"marketCap":308814429},{"date":"2022-09-16","current":-6.129031,"twenty":-19.393433,"median":-13.317212,"eighty":-11.844209,"marketCap":307945619},{"date":"2022-09-23","current":-5.527907,"twenty":-19.377706,"median":-13.304479,"eighty":-11.805952,"marketCap":269452416},{"date":"2022-09-30","current":-5.268219,"twenty":-19.358729,"median":-13.29424,"eighty":-11.739355,"marketCap":258984966},{"date":"2022-10-07","current":-3.334511,"twenty":-19.313349,"median":-13.281408,"eighty":-11.574558,"marketCap":163427280},{"date":"2022-10-14","current":-3.192899,"twenty":-19.240081,"median":-13.26552,"eighty":-11.519941,"marketCap":155998767},{"date":"2022-10-21","current":-3.776992,"twenty":-19.189017,"median":-13.2607,"eighty":-11.419826,"marketCap":185712818},{"date":"2022-10-28","current":-3.404363,"twenty":-19.175941,"median":-13.241782,"eighty":-11.34035,"marketCap":169704373},{"date":"2022-11-04","current":-2.493588,"twenty":-19.155403,"median":-13.21909,"eighty":-11.293284,"marketCap":123921098},{"date":"2022-11-11","current":-1.962841,"twenty":-19.119693,"median":-13.202703,"eighty":-11.220822,"marketCap":101635560},{"date":"2022-11-18","current":-1.709372,"twenty":-19.040002,"median":-13.169144,"eighty":-11.073401,"marketCap":88804493},{"date":"2022-11-25","current":-1.59989,"twenty":-18.960552,"median":-13.089194,"eighty":-10.924331,"marketCap":83401938},{"date":"2022-12-02","current":-1.271834,"twenty":-18.879299,"median":-13.066255,"eighty":-10.549888,"marketCap":66856614},{"date":"2022-12-09","current":-5.585763,"twenty":-18.659925,"median":-13.055482,"eighty":-10.38824,"marketCap":291250318},{"date":"2022-12-16","current":-4.830297,"twenty":-18.384979,"median":-13.024782,"eighty":-10.32247,"marketCap":253408050},{"date":"2022-12-23","current":-6.371604,"twenty":-18.295522,"median":-12.990589,"eighty":-10.187317,"marketCap":334836503},{"date":"2022-12-30","current":-7.188594,"twenty":-18.170479,"median":-12.982972,"eighty":-10.008759,"marketCap":380112075},{"date":"2023-01-06","current":-7.688928,"twenty":-18.154652,"median":-12.903124,"eighty":-9.752954,"marketCap":403763493},{"date":"2023-01-13","current":-5.706058,"twenty":-18.104257,"median":-12.846213,"eighty":-7.688928,"marketCap":305441169},{"date":"2023-01-20","current":-6.459312,"twenty":-17.9977,"median":-12.837332,"eighty":-7.374204,"marketCap":346324335},{"date":"2023-01-27","current":-5.951135,"twenty":-17.857094,"median":-12.821298,"eighty":-6.862976,"marketCap":319632020},{"date":"2023-02-03","current":-5.776873,"twenty":-17.539987,"median":-12.756949,"eighty":-6.367933,"marketCap":310171453},{"date":"2023-02-10","current":-6.06212,"twenty":-17.052096,"median":-12.693639,"eighty":-6.243368,"marketCap":320307775},{"date":"2023-02-17","current":-5.565251,"twenty":-16.755938,"median":-12.64181,"eighty":-6.151395,"marketCap":293615460},{"date":"2023-02-24","current":-5.080906,"twenty":-16.600297,"median":-12.612561,"eighty":-6.08797,"marketCap":265233759},{"date":"2023-03-03","current":-5.604926,"twenty":-16.439572,"median":-12.581052,"eighty":-6.019199,"marketCap":293953338},{"date":"2023-03-10","current":-4.059398,"twenty":-16.126823,"median":-12.554737,"eighty":-5.957727,"marketCap":214214271},{"date":"2023-03-17","current":-4.759844,"twenty":-15.898426,"median":-12.5386,"eighty":-5.915214,"marketCap":251042908},{"date":"2023-03-24","current":-4.748457,"twenty":-15.814998,"median":-12.484354,"eighty":-5.839251,"marketCap":252732295},{"date":"2023-03-31","current":-5.062872,"twenty":-15.558556,"median":-12.41617,"eighty":-5.818726,"marketCap":272160245},{"date":"2023-04-06","current":-5.515395,"twenty":-15.2868,"median":-12.393076,"eighty":-5.798276,"marketCap":298007866},{"date":"2023-04-14","current":-3.407139,"twenty":-15.104598,"median":-12.376683,"eighty":-5.751686,"marketCap":287439901},{"date":"2023-04-21","current":-3.423024,"twenty":-15.075219,"median":-12.365371,"eighty":-5.695738,"marketCap":286594490},{"date":"2023-04-28","current":-3.621546,"twenty":-14.971826,"median":-12.310085,"eighty":-5.661512,"marketCap":304686295},{"date":"2023-05-05","current":-3.635585,"twenty":-14.858222,"median":-12.26867,"eighty":-5.593428,"marketCap":305362624},{"date":"2023-05-12","current":-3.330904,"twenty":-14.826016,"median":-12.249364,"eighty":-5.568587,"marketCap":277633128},{"date":"2023-05-19","current":-3.332274,"twenty":-14.818952,"median":-12.234113,"eighty":-5.5204,"marketCap":297584839},{"date":"2023-05-26","current":-3.231497,"twenty":-14.811441,"median":-12.222059,"eighty":-5.439393,"marketCap":287439901},{"date":"2023-06-02","current":-3.434585,"twenty":-14.791955,"median":-12.201472,"eighty":-5.312927,"marketCap":305832502},{"date":"2023-06-09","current":-3.407273,"twenty":-14.764775,"median":-12.198453,"eighty":-5.28475,"marketCap":304479261},{"date":"2023-06-16","current":-4.170938,"twenty":-14.740265,"median":-12.160354,"eighty":-5.07843,"marketCap":377892593},{"date":"2023-06-23","current":-4.359744,"twenty":-14.731325,"median":-12.152393,"eighty":-5.057591,"marketCap":396297439},{"date":"2023-06-30","current":-7.00064,"twenty":-14.718305,"median":-12.136009,"eighty":-5.055831,"marketCap":632126719},{"date":"2023-07-07","current":-7.084548,"twenty":-14.696694,"median":-12.097209,"eighty":-5.062872,"marketCap":638244074},{"date":"2023-07-14","current":-6.875228,"twenty":-14.6624,"median":-12.079819,"eighty":-5.068525,"marketCap":638244074},{"date":"2023-07-21","current":-7.028003,"twenty":-14.653302,"median":-12.064139,"eighty":-5.080906,"marketCap":649663138},{"date":"2023-07-28","current":-7.498848,"twenty":-14.622905,"median":-12.04158,"eighty":-5.207419,"marketCap":683512504},{"date":"2023-08-04","current":-7.953511,"twenty":-14.601036,"median":-12.024634,"eighty":-5.228713,"marketCap":722255754},{"date":"2023-08-11","current":-7.354477,"twenty":-14.583407,"median":-11.998532,"eighty":-5.261383,"marketCap":747059362},{"date":"2023-08-18","current":-7.862758,"twenty":-14.572779,"median":-11.956319,"eighty":-5.28475,"marketCap":788698737},{"date":"2023-08-25","current":-7.637624,"twenty":-14.506463,"median":-11.943194,"eighty":-5.298861,"marketCap":762796904},{"date":"2023-08-31","current":-8.133422,"twenty":-14.4867,"median":-11.921598,"eighty":-5.305964,"marketCap":813459365},{"date":"2023-09-08","current":-7.866907,"twenty":-14.484166,"median":-11.909309,"eighty":-5.312927,"marketCap":776279656},{"date":"2023-09-15","current":-8.565073,"twenty":-14.483879,"median":-11.869315,"eighty":-5.324599,"marketCap":842467710},{"date":"2023-09-22","current":-8.218785,"twenty":-14.422991,"median":-11.843691,"eighty":-5.364732,"marketCap":808147978},{"date":"2023-09-29","current":-8.499622,"twenty":-14.407261,"median":-11.810464,"eighty":-5.391254,"marketCap":828167822},{"date":"2023-10-06","current":-8.075664,"twenty":-14.404891,"median":-11.805298,"eighty":-5.421144,"marketCap":784042452},{"date":"2023-10-13","current":-7.97887,"twenty":-14.393189,"median":-11.762441,"eighty":-5.494747,"marketCap":776279656},{"date":"2023-10-20","current":-7.871535,"twenty":-14.374592,"median":-11.67635,"eighty":-5.497417,"marketCap":767699722},{"date":"2023-10-27","current":-7.699507,"twenty":-14.37054,"median":-11.628617,"eighty":-5.497654,"marketCap":747679879},{"date":"2023-11-03","current":-7.17043,"twenty":-14.351862,"median":-11.573402,"eighty":-5.505177,"marketCap":701920236},{"date":"2023-11-10","current":-5.970942,"twenty":-14.325681,"median":-11.546094,"eighty":-5.518658,"marketCap":686476556},{"date":"2023-11-17","current":-5.487665,"twenty":-14.300392,"median":-11.499199,"eighty":-5.518658,"marketCap":639755166},{"date":"2023-11-24","current":-5.931936,"twenty":-14.283081,"median":-11.456561,"eighty":-5.501771,"marketCap":694263454},{"date":"2023-12-01","current":-6.025826,"twenty":-14.216157,"median":-11.367098,"eighty":-5.517027,"marketCap":705329046},{"date":"2023-12-08","current":-11.439876,"twenty":-14.20757,"median":-11.347894,"eighty":-5.524424,"marketCap":1324602518},{"date":"2023-12-15","current":-11.41059,"twenty":-14.202076,"median":-11.375314,"eighty":-5.532271,"marketCap":1346488162},{"date":"2023-12-22","current":-11.925452,"twenty":-14.184853,"median":-11.42744,"eighty":-5.551316,"marketCap":1406934225},{"date":"2023-12-29","current":-12.247032,"twenty":-14.141201,"median":-11.449501,"eighty":-5.556079,"marketCap":1455916379},{"date":"2024-01-05","current":-11.217845,"twenty":-14.124263,"median":-11.444688,"eighty":-5.560701,"marketCap":1319391651},{"date":"2024-01-12","current":-13.194311,"twenty":-14.118795,"median":-11.460366,"eighty":-5.568587,"marketCap":1550325393},{"date":"2024-01-19","current":-14.465426,"twenty":-14.174814,"median":-11.47464,"eighty":-5.574125,"marketCap":1686754028},{"date":"2024-01-26","current":-14.983944,"twenty":-14.20757,"median":-11.499199,"eighty":-5.577066,"marketCap":1742861042},{"date":"2024-02-02","current":-15.192524,"twenty":-14.300739,"median":-11.528223,"eighty":-5.581389,"marketCap":1768847449},{"date":"2024-02-09","current":-14.748842,"twenty":-14.393189,"median":-11.54682,"eighty":-5.589596,"marketCap":1703881432},{"date":"2024-02-16","current":-13.65194,"twenty":-14.404891,"median":-11.567624,"eighty":-5.608959,"marketCap":1576311800},{"date":"2024-02-23","current":-14.13304,"twenty":-14.396825,"median":-11.581834,"eighty":-5.625092,"marketCap":1640687216},{"date":"2024-03-01","current":-10.303743,"twenty":-14.378644,"median":-11.573402,"eighty":-5.629721,"marketCap":1195373004},{"date":"2024-03-08","current":-12.093153,"twenty":-14.358385,"median":-11.567624,"eighty":-5.636181,"marketCap":1418455194},{"date":"2024-03-15","current":-10.896325,"twenty":-14.342077,"median":-11.552539,"eighty":-5.658684,"marketCap":1273758779},{"date":"2024-03-22","current":-11.538805,"twenty":-14.301086,"median":-11.546205,"eighty":-5.665753,"marketCap":1344762225},{"date":"2024-03-28","current":-10.904189,"twenty":-14.299698,"median":-11.538805,"eighty":-5.674035,"marketCap":1264076491},{"date":"2024-04-05","current":-10.349243,"twenty":-14.288877,"median":-11.507756,"eighty":-5.680711,"marketCap":1206520668},{"date":"2024-04-12","current":-11.107813,"twenty":-14.231653,"median":-11.490879,"eighty":-5.687459,"marketCap":1200065809},{"date":"2024-04-19","current":-9.215802,"twenty":-14.210621,"median":-11.46913,"eighty":-5.702618,"marketCap":991303742},{"date":"2024-04-26","current":-11.339937,"twenty":-14.20395,"median":-11.459096,"eighty":-5.715476,"marketCap":1225406418},{"date":"2024-05-03","current":-11.733497,"twenty":-14.200071,"median":-11.46913,"eighty":-5.724599,"marketCap":1266307115},{"date":"2024-05-10","current":-9.668623,"twenty":-14.189365,"median":-11.459096,"eighty":-5.733174,"marketCap":1107009662},{"date":"2024-05-17","current":-10.115404,"twenty":-14.156013,"median":-11.42744,"eighty":-5.759289,"marketCap":1168360708},{"date":"2024-05-24","current":-9.147602,"twenty":-14.136092,"median":-11.375314,"eighty":-5.774576,"marketCap":1052116621},{"date":"2024-05-31","current":-8.827191,"twenty":-14.129207,"median":-11.35501,"eighty":-5.782121,"marketCap":1017135762},{"date":"2024-06-07","current":-7.823819,"twenty":-14.123069,"median":-11.339823,"eighty":-5.787829,"marketCap":904658844},{"date":"2024-06-14","current":-8.515887,"twenty":-14.119026,"median":-11.316994,"eighty":-5.792437,"marketCap":974082396},{"date":"2024-06-21","current":-8.52603,"twenty":-14.116428,"median":-11.288753,"eighty":-5.797709,"marketCap":970853394},{"date":"2024-06-28","current":-8.52006,"twenty":-14.116197,"median":-11.262481,"eighty":-5.798843,"marketCap":969238893},{"date":"2024-07-05","current":-7.963908,"twenty":-14.11303,"median":-11.251924,"eighty":-5.805313,"marketCap":914884019},{"date":"2024-07-12","current":-8.497692,"twenty":-14.104041,"median":-11.224936,"eighty":-5.814579,"marketCap":981616735},{"date":"2024-07-15","current":-8.709438,"twenty":-14.101747,"median":-11.224715,"eighty":-5.815211,"marketCap":1010139590},{"date":"2024-08-02","current":-7.485095,"twenty":-14.099454,"median":-11.224493,"eighty":-5.815842,"marketCap":857838309},{"date":"2024-08-09","current":-7.640912,"twenty":-14.094802,"median":-11.205504,"eighty":-5.819476,"marketCap":885822997},{"date":"2024-08-16","current":-8.240501,"twenty":-14.093907,"median":-11.162588,"eighty":-5.823431,"marketCap":1032742607},{"date":"2024-08-23","current":-7.760367,"twenty":-14.048436,"median":-11.118035,"eighty":-5.826337,"marketCap":983480417},{"date":"2024-08-30","current":-7.393035,"twenty":-14.034683,"median":-11.087899,"eighty":-5.833183,"marketCap":934333400},{"date":"2024-09-06","current":-8.155019,"twenty":-14.033224,"median":-11.020127,"eighty":-5.839251,"marketCap":1031547280},{"date":"2024-09-13","current":-8.802104,"twenty":-14.027088,"median":-10.978779,"eighty":-5.849019,"marketCap":1108238229},{"date":"2024-09-20","current":-8.962749,"twenty":-13.99324,"median":-10.957045,"eighty":-5.877056,"marketCap":1139022624},{"date":"2024-09-27","current":-8.000083,"twenty":-13.961974,"median":-10.894902,"eighty":-5.894802,"marketCap":1020205660},{"date":"2024-10-04","current":-7.688355,"twenty":-13.947654,"median":-10.874176,"eighty":-5.909483,"marketCap":966197949},{"date":"2024-10-11","current":-7.725025,"twenty":-13.936046,"median":-10.812773,"eighty":-5.924083,"marketCap":962957487},{"date":"2024-10-18","current":-9.289256,"twenty":-13.925882,"median":-10.792815,"eighty":-5.928401,"marketCap":1147663858},{"date":"2024-10-25","current":-9.347449,"twenty":-13.904362,"median":-10.773913,"eighty":-5.930655,"marketCap":1151984475},{"date":"2024-10-31","current":-10.81176,"twenty":-13.888979,"median":-10.69668,"eighty":-5.935928,"marketCap":1339391232},{"date":"2024-11-08","current":-9.795031,"twenty":-13.882336,"median":-10.614452,"eighty":-5.945603,"marketCap":1205452109},{"date":"2024-11-15","current":-7.934741,"twenty":-13.880109,"median":-10.567811,"eighty":-5.951569,"marketCap":1109858461},{"date":"2024-11-22","current":-8.193559,"twenty":-13.878421,"median":-10.530141,"eighty":-5.955891,"marketCap":1136322239},{"date":"2024-11-29","current":-8.515548,"twenty":-13.874795,"median":-10.499116,"eighty":-5.962822,"marketCap":1187704999},{"date":"2024-12-06","current":-7.575701,"twenty":-13.869107,"median":-10.430822,"eighty":-5.969,"marketCap":1058630209},{"date":"2024-12-13","current":-7.438607,"twenty":-13.864864,"median":-10.405945,"eighty":-5.972,"marketCap":1031513657},{"date":"2024-12-20","current":-7.511117,"twenty":-13.847086,"median":-10.370165,"eighty":-5.976517,"marketCap":1030971326},{"date":"2024-12-27","current":-7.680726,"twenty":-13.801742,"median":-10.357252,"eighty":-5.977661,"marketCap":1057545547},{"date":"2025-01-03","current":-7.415916,"twenty":-13.792864,"median":-10.345951,"eighty":-6.00833,"marketCap":1005481766},{"date":"2025-01-10","current":-7.387777,"twenty":-13.788234,"median":-10.323543,"eighty":-6.019199,"marketCap":1005481766},{"date":"2025-01-17","current":-6.953437,"twenty":-13.781733,"median":-10.297117,"eighty":-6.023626,"marketCap":946367682},{"date":"2025-01-24","current":-7.612205,"twenty":-13.774759,"median":-10.284647,"eighty":-6.025423,"marketCap":1047783588},{"date":"2025-01-31","current":-6.977006,"twenty":-13.765434,"median":-10.25901,"eighty":-6.034301,"marketCap":961552951},{"date":"2025-02-07","current":-7.219276,"twenty":-13.753463,"median":-10.232674,"eighty":-6.052543,"marketCap":990296497},{"date":"2025-02-14","current":-6.822516,"twenty":-13.740454,"median":-10.115609,"eighty":-6.061351,"marketCap":942029033},{"date":"2025-02-21","current":-6.467941,"twenty":-13.734308,"median":-10.093087,"eighty":-6.062421,"marketCap":894846232},{"date":"2025-02-28","current":-6.133931,"twenty":-13.727465,"median":-10.02417,"eighty":-6.065143,"marketCap":843867113},{"date":"2025-03-07","current":-5.852269,"twenty":-13.71316,"median":-9.970579,"eighty":-6.049778,"marketCap":837901472},{"date":"2025-03-14","current":-6.385184,"twenty":-13.708332,"median":-9.910974,"eighty":-6.026825,"marketCap":917081805},{"date":"2025-03-21","current":-5.844642,"twenty":-13.700767,"median":-9.829627,"eighty":-6.025288,"marketCap":838443803},{"date":"2025-03-28","current":-5.916884,"twenty":-13.679442,"median":-9.795031,"eighty":-5.984934,"marketCap":844409444},{"date":"2025-04-04","current":-5.41793,"twenty":-13.665275,"median":-9.712775,"eighty":-5.969,"marketCap":792887995},{"date":"2025-04-11","current":-4.319691,"twenty":-13.654878,"median":-9.636637,"eighty":-5.953745,"marketCap":648468389},{"date":"2025-04-17","current":-4.898467,"twenty":-13.65194,"median":-9.603412,"eighty":-5.931936,"marketCap":747645908},{"date":"2025-04-25","current":-5.660159,"twenty":-13.648303,"median":-9.484661,"eighty":-5.916884,"marketCap":862626437},{"date":"2025-05-02","current":-6.426634,"twenty":-13.611466,"median":-9.396394,"eighty":-5.918352,"marketCap":972702584},{"date":"2025-05-09","current":-6.135697,"twenty":-13.604729,"median":-9.345786,"eighty":-5.927903,"marketCap":928563139},{"date":"2025-05-16","current":-5.081075,"twenty":-13.598948,"median":-9.280564,"eighty":-5.916884,"marketCap":866985889},{"date":"2025-05-23","current":-5.189286,"twenty":-13.570194,"median":-9.208581,"eighty":-5.882056,"marketCap":893142597},{"date":"2025-05-30","current":-5.256736,"twenty":-13.527456,"median":-9.173722,"eighty":-5.851134,"marketCap":911125334},{"date":"2025-06-06","current":-5.007101,"twenty":-13.509055,"median":-9.060878,"eighty":-5.837961,"marketCap":874614929},{"date":"2025-06-13","current":-5.317982,"twenty":-13.49872,"median":-8.982791,"eighty":-5.819476,"marketCap":938916836},{"date":"2025-06-20","current":-5.183436,"twenty":-13.485895,"median":-8.943559,"eighty":-5.800161,"marketCap":906765882},{"date":"2025-06-27","current":-5.465947,"twenty":-13.472919,"median":-8.879507,"eighty":-5.782121,"marketCap":975427241},{"date":"2025-07-03","current":-5.649134,"twenty":-13.4687,"median":-8.851321,"eighty":-5.729733,"marketCap":1013572441},{"date":"2025-07-11","current":-6.060959,"twenty":-13.466131,"median":-8.823918,"eighty":-5.695738,"marketCap":1080599005},{"date":"2025-07-18","current":-7.314861,"twenty":-13.46266,"median":-8.816193,"eighty":-5.710767,"marketCap":1293122259},{"date":"2025-07-25","current":-7.006501,"twenty":-13.460198,"median":-8.785147,"eighty":-5.721214,"marketCap":1257999997},{"date":"2025-08-01","current":-8.237689,"twenty":-13.451559,"median":-8.722056,"eighty":-5.729733,"marketCap":1437436162},{"date":"2025-08-08","current":-8.281316,"twenty":-13.442628,"median":-8.688191,"eighty":-5.747092,"marketCap":1469250645},{"date":"2025-08-15","current":-8.47781,"twenty":-13.428755,"median":-8.660023,"eighty":-5.769982,"marketCap":1662306709},{"date":"2025-08-22","current":-8.638654,"twenty":-13.403956,"median":-8.63053,"eighty":-5.780372,"marketCap":1688336740},{"date":"2025-08-29","current":-8.414646,"twenty":-13.396944,"median":-8.638654,"eighty":-5.787092,"marketCap":1651460863},{"date":"2025-09-05","current":-8.112917,"twenty":-13.396458,"median":-8.622065,"eighty":-5.790869,"marketCap":1589278011},{"date":"2025-09-12","current":-8.597222,"twenty":-13.393909,"median":-8.60362,"eighty":-5.797709,"marketCap":1699182587},{"date":"2025-09-19","current":-8.94501,"twenty":-13.385494,"median":-8.610019,"eighty":-5.800038,"marketCap":1774380454},{"date":"2025-09-26","current":-9.045131,"twenty":-13.370479,"median":-8.627645,"eighty":-5.80289,"marketCap":1777272680},{"date":"2025-10-03","current":-8.512022,"twenty":-13.360301,"median":-8.638654,"eighty":-5.813948,"marketCap":1676044781},{"date":"2025-10-10","current":-8.486281,"twenty":-13.357847,"median":-8.622235,"eighty":-5.817225,"marketCap":1651460863},{"date":"2025-10-17","current":-8.047023,"twenty":-13.353429,"median":-8.597222,"eighty":-5.821028,"marketCap":1580601334},{"date":"2025-10-24","current":-8.513119,"twenty":-13.347233,"median":-8.60362,"eighty":-5.824758,"marketCap":1663029766},{"date":"2025-10-31","current":-8.263348,"twenty":-13.342738,"median":-8.57038,"eighty":-5.828443,"marketCap":1608077478},{"date":"2025-11-07","current":-8.118597,"twenty":-13.33536,"median":-8.561701,"eighty":-5.835563,"marketCap":1576262995},{"date":"2025-11-14","current":-8.953433,"twenty":-13.315064,"median":-8.562935,"eighty":-5.839457,"marketCap":1754134874},{"date":"2025-11-21","current":-8.32101,"twenty":-13.306363,"median":-8.564004,"eighty":-5.842723,"marketCap":1572018786},{"date":"2025-11-28","current":-9.70873,"twenty":-13.305926,"median":-8.567726,"eighty":-5.844642,"marketCap":1843549304},{"date":"2025-12-05","current":-9.421046,"twenty":-13.303031,"median":-8.581097,"eighty":-5.846596,"marketCap":1798727281},{"date":"2025-12-12","current":-8.095034,"twenty":-13.295471,"median":-8.575738,"eighty":-5.852269,"marketCap":1557727706},{"date":"2025-12-19","current":-8.116161,"twenty":-13.29424,"median":-8.562935,"eighty":-5.853536,"marketCap":1560326085},{"date":"2025-12-26","current":-8.732727,"twenty":-13.291734,"median":-8.57038,"eighty":-5.866198,"marketCap":1684398642},{"date":"2026-01-02","current":-9.374295,"twenty":-13.28902,"median":-8.597222,"eighty":-5.876979,"marketCap":1802624848},{"date":"2026-01-09","current":-8.51177,"twenty":-13.280164,"median":-8.575738,"eighty":-5.882433,"marketCap":1623986350},{"date":"2026-01-16","current":-8.766662,"twenty":-13.272619,"median":-8.610019,"eighty":-5.888715,"marketCap":1666209995},{"date":"2026-01-23","current":-9.448662,"twenty":-13.268752,"median":-8.622065,"eighty":-5.894114,"marketCap":1817565522},{"date":"2026-01-30","current":-9.241158,"twenty":-13.264633,"median":-8.634183,"eighty":-5.904462,"marketCap":1805223226},{"date":"2026-02-06","current":-8.459688,"twenty":-13.260074,"median":-8.637068,"eighty":-5.918058,"marketCap":1633080673},{"date":"2026-02-13","current":-8.89399,"twenty":-13.217763,"median":-8.637068,"eighty":-5.918058,"marketCap":1727921476},{"date":"2026-02-20","current":-9.442084,"twenty":-13.195802,"median":-8.637068,"eighty":-5.918058,"marketCap":1818864712},{"date":"2026-02-27","current":-9.418754,"twenty":-13.077142,"median":-8.637068,"eighty":-5.918058,"marketCap":1818864712},{"date":"2026-03-06","current":-8.866459,"twenty":-13.050618,"median":-8.637068,"eighty":-5.918058,"marketCap":1678552291},{"date":"2026-03-13","current":-9.080009,"twenty":-12.99028,"median":-8.637068,"eighty":-5.918058,"marketCap":1713630396},{"date":"2026-03-20","current":-8.989812,"twenty":-12.872607,"median":-8.637068,"eighty":-5.918058,"marketCap":1697390533},{"date":"2026-03-27","current":-9.422218,"twenty":-12.835328,"median":-8.637068,"eighty":-5.918058,"marketCap":1779239445},{"date":"2026-04-02","current":-10.121514,"twenty":-12.76463,"median":-8.637068,"eighty":-5.918058,"marketCap":1913055920},{"date":"2026-04-10","current":-8.614145,"twenty":-12.646197,"median":-8.634183,"eighty":-5.918058,"marketCap":1770589741},{"date":"2026-04-17","current":-9.098299,"twenty":-12.580967,"median":-8.627645,"eighty":-5.918058,"marketCap":1882437117},{"date":"2026-04-24","current":-8.672978,"twenty":-12.531366,"median":-8.627645,"eighty":-5.918058,"marketCap":1784979462},{"date":"2026-05-01","current":-9.840216,"twenty":-12.408666,"median":-8.627645,"eighty":-5.918058,"marketCap":2028296560},{"date":"2026-05-08","current":-9.387238,"twenty":-12.372989,"median":-8.627645,"eighty":-5.918058,"marketCap":1941304156},{"date":"2026-05-15","current":-10.205734,"twenty":-12.288471,"median":-8.627645,"eighty":-5.918058,"marketCap":2008020135},{"date":"2026-05-22","current":-10.228389,"twenty":-12.254036,"median":-8.627645,"eighty":-5.918058,"marketCap":1997554883},{"date":"2026-05-29","current":-10.59007,"twenty":-12.233824,"median":-8.622406,"eighty":-5.917765,"marketCap":2080240286},{"date":"2026-06-05","current":-11.245266,"twenty":-12.202715,"median":-8.627645,"eighty":-5.918058,"marketCap":2203549908},{"date":"2026-06-12","current":-11.54906,"twenty":-12.154142,"median":-8.627645,"eighty":-5.918058,"marketCap":2243259786},{"date":"2026-06-18","current":-12.068208,"twenty":-12.129758,"median":-8.627645,"eighty":-5.918058,"marketCap":2334681645},{"date":"2026-06-26","current":-12.126491,"twenty":-12.093842,"median":-8.622406,"eighty":-5.917765,"marketCap":2326994875},{"date":"2026-07-02","current":-12.298451,"twenty":-12.093842,"median":-8.622406,"eighty":-5.917765,"marketCap":2372416697},{"date":"2026-07-10","current":-13.041486,"twenty":-12.086912,"median":-8.622406,"eighty":-5.917765,"marketCap":2512874946},{"date":"2026-07-17","current":-12.197585,"twenty":-12.086912,"median":-8.622406,"eighty":-5.917765,"marketCap":2352151577},{"date":"2026-07-24","current":-12.127093,"twenty":-12.086912,"median":-8.622406,"eighty":-5.917765,"marketCap":2324199686},{"date":"2026-07-31","current":-12.200057,"twenty":-12.075175,"median":-8.622235,"eighty":-5.917471,"marketCap":2367525116},{"date":"2026-08-07","current":-12.393886,"twenty":-12.081578,"median":-8.622235,"eighty":-5.917471,"marketCap":2407356560},{"date":"2026-08-14","current":-12.119292,"twenty":-12.094187,"median":-8.622235,"eighty":-5.917471,"marketCap":2389761384},{"date":"2026-08-21","current":-12.797528,"twenty":-12.094187,"median":-8.622235,"eighty":-5.917471,"marketCap":2554741973},{"date":"2026-08-28","current":-13.045486,"twenty":-12.094187,"median":-8.622235,"eighty":-5.917471,"marketCap":2597566722},{"date":"2026-09-01","current":-12.262524,"twenty":-12.094187,"median":-8.622235,"eighty":-5.917471,"marketCap":2429777952}],"updateTime":1788369206323},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PHVS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649253206","title":"Pharvaris Says FDA Accepts NDA for Deucrictibant in Hereditary Angioedema Attacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2649253206","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649253206?lang=en_us&edition=fundamental","pubTime":"2026-07-06 18:50","pubTimestamp":1783335017,"startTime":"0","endTime":"0","summary":"Pharvaris says FDA accepts NDA for deucrictibant in hereditary angioedema attacksPharvaris secured FDA acceptance of its NDA for deucrictibant IR 20 mg to treat hereditary angioedema attacks on demand","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL8rNH33:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00BKPKM429.USD","LU2210149790.SGD","BK4588","LU2095319765.USD","BK4007","BK4112","SG9999014021.USD","SG9999014013.SGD","LU2210150020.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","SG9999014005.SGD","BCDF","NDAQ","PHVS","BK4585","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649625884","title":"Pharvaris Nv - FDA Sets Pdufa Action Date for Deucrictibant Ir Nda as April 23, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2649625884","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649625884?lang=en_us&edition=fundamental","pubTime":"2026-07-06 18:50","pubTimestamp":1783335000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUA3SMJPY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PHVS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649625859","title":"Pharvaris Announces FDA Acceptance of New Drug Application for Deucrictibant Ir for On-demand Treatment of Hereditary Angioedema Attacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2649625859","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649625859?lang=en_us&edition=fundamental","pubTime":"2026-07-06 18:50","pubTimestamp":1783335000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUA3SMJPY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PHVS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648252280","title":"Pharvaris Chief Early Development Anne Lesage Disposes of Common Shares Worth $2,661,782.82","url":"https://stock-news.laohu8.com/highlight/detail?id=2648252280","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648252280?lang=en_us&edition=fundamental","pubTime":"2026-07-02 07:03","pubTimestamp":1782946996,"startTime":"0","endTime":"0","summary":"Pharvaris Chief Early Development Anne Lesage disposes of common shares worth $2,661,782.82Pharvaris: Chief Early Development Anne Lesage reported option exercises and share sales on June 29-30.Dispos","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL3GQKFV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Pharvaris Chief Early Development Anne Lesage Disposes of Common Shares Worth $2,661,782.82","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647553294","title":"Cantor Fitzgerald Reaffirms Their Buy Rating on Pharvaris (PHVS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2647553294","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647553294?lang=en_us&edition=fundamental","pubTime":"2026-06-30 19:46","pubTimestamp":1782819960,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Steven Seedhouse from Cantor Fitzgerald maintained a Buy rating on Pharvaris, with a price target of $46.00. The co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-reaffirms-their-buy-rating-on-pharvaris-phvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-reaffirms-their-buy-rating-on-pharvaris-phvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647300357","title":"Pharvaris Chief Medical Officer Lu Peng Disposes of 29,700 Common Shares for $1.02 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2647300357","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647300357?lang=en_us&edition=fundamental","pubTime":"2026-06-30 06:18","pubTimestamp":1782771538,"startTime":"0","endTime":"0","summary":"Pharvaris Chief Medical Officer Lu Peng disposes of 29,700 common shares for $1.02 millionPharvaris Chief Medical Officer Lu Peng exercised stock options, acquiring 29,700 common shares on June 25-26 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDLlyQfy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Pharvaris Chief Medical Officer Lu Peng Disposes of 29,700 Common Shares for $1.02 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646694523","title":"Pharvaris Shareholders Approve 2025 Accounts and Renew Board Authorities at 2026 AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2646694523","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646694523?lang=en_us&edition=fundamental","pubTime":"2026-06-26 23:47","pubTimestamp":1782488840,"startTime":"0","endTime":"0","summary":"An update from Pharvaris ( ($PHVS) ) is now available. On June 26, 2026, Pharvaris N.V. held its Annual General Meeting of Shareholders, at which i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pharvaris-shareholders-approve-2025-accounts-and-renew-board-authorities-at-2026-agm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pharvaris-shareholders-approve-2025-accounts-and-renew-board-authorities-at-2026-agm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4229","BK4007","PHVS","BK4195","AGM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646366704","title":"Pharvaris Shareholders Adopt Dutch Statutory Annual Accounts for Fy2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2646366704","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646366704?lang=en_us&edition=fundamental","pubTime":"2026-06-26 23:28","pubTimestamp":1782487682,"startTime":"0","endTime":"0","summary":"Pharvaris shareholders adopt Dutch statutory annual accounts for FY2025Pharvaris held its annual shareholder meeting on June 26, 2026.Shareholders adopted the Dutch statutory annual accounts for the f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL3WrJlz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646005648","title":"Pharvaris is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2646005648","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646005648?lang=en_us&edition=fundamental","pubTime":"2026-06-26 01:43","pubTimestamp":1782409380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PHVS/analyst-ratings(END) Dow Jones NewswiresJune 25, 2026 13:43 ET","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646872837","title":"Pharvaris price target raised to $46 from $41 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2646872837","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646872837?lang=en_us&edition=fundamental","pubTime":"2026-06-25 18:50","pubTimestamp":1782384628,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Maxwell Skor raised the firm’s price target on Pharvaris (PHVS) to $46 from $41 and keeps an Overweight rating on the shares...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pharvaris-price-target-raised-to-46-from-41-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pharvaris-price-target-raised-to-46-from-41-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHVS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645580854","title":"Pharvaris CMO Lu Peng disposes of 300 shares worth $10,200","url":"https://stock-news.laohu8.com/highlight/detail?id=2645580854","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645580854?lang=en_us&edition=fundamental","pubTime":"2026-06-24 05:08","pubTimestamp":1782248887,"startTime":"0","endTime":"0","summary":"Pharvaris Chief Medical Officer Lu Peng sold 300 common shares on June 18 at USD 34.Sale followed the exercise of 300 stock options at USD 2.59.Lu Peng ended the day with 65,631 common shares beneficially owned.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharvaris NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDLSqKgL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Pharvaris CMO Lu Peng disposes of 300 shares worth $10,200","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHVS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644033145","title":"Pharvaris (PHVS) Is Up 6.0% After Strong Phase 3 Oral HAE Data With Novel Endpoint Introduction","url":"https://stock-news.laohu8.com/highlight/detail?id=2644033145","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644033145?lang=en_us&edition=fundamental","pubTime":"2026-06-19 02:26","pubTimestamp":1781807181,"startTime":"0","endTime":"0","summary":"At the EAACI 2026 congress in Istanbul, Pharvaris reported Phase 3 RAPIDe-3 data showing rapid, sustained efficacy and favorable safety for its oral deucrictibant capsule in treating hereditary angioedema attacks, alongside supportive long-term prophylaxis and cardiovascular safety findings.\nA distinctive feature of the update was the introduction of the End of Progression™ endpoint, highlighting how quickly deucrictibant can halt worsening symptoms and potentially improve patients’...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/pharvaris-phvs-is-up-60-after-strong-phase-3-oral-hae-data-w","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/pharvaris-phvs-is-up-60-after-strong-phase-3-oral-hae-data-w","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BLDYK493.USD","BK4007","LU0205194284.USD","HAE","IE00B64QTZ34.USD","LU1169590202.USD","LU1169589451.USD","IE0034390439.USD","BK4198","IE00B19Z6F94.USD","LU0205193047.USD","LU0012050646.USD","PHVS","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643755751","title":"Analysts Are Bullish on Top Healthcare Stocks: Crinetics Pharmaceuticals (CRNX), Pharvaris (PHVS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2643755751","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643755751?lang=en_us&edition=fundamental","pubTime":"2026-06-16 18:10","pubTimestamp":1781604614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Crinetics Pharmaceuticals (CRNX), Pharvaris (PHVS) a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-crinetics-pharmaceuticals-crnx-pharvaris-phvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-crinetics-pharmaceuticals-crnx-pharvaris-phvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRNX","PHVS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643277710","title":"Pharvaris says Phase 3 RAPIDe-3 trial shows oral deucrictibant cuts median HAE symptom relief time to 1.28 hours","url":"https://stock-news.laohu8.com/highlight/detail?id=2643277710","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643277710?lang=en_us&edition=fundamental","pubTime":"2026-06-15 18:50","pubTimestamp":1781520624,"startTime":"0","endTime":"0","summary":"Pharvaris highlighted clinical data on oral bradykinin B2 antagonist deucrictibant at EAACI 2026, with results already presented during June 12-15.Phase 3 RAPIDe-3 findings supported rapid symptom improvement with limited need for additional dosing or rescue treatment, with a clean tolerability profile.A prespecified “end of progression” analysis indicated earlier control of attack worsening versus placebo, reinforcing potential differentiation for on-demand use.Long-term Phase 2 extension results supported durable prevention of HAE attacks, improved disease control, better quality of life, no meaningful safety signals.An integrated cardiovascular review across roughly 570 treated participants showed no signal for clinically meaningful cardiac risk, supporting broader development in HAE.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL4vv6MG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHVS","SG9999014039.USD","BK4588","LU2210150020.SGD","BK4007","NDAQ","IE00BN0W2V16.EUR","LU0314104364.USD","IE00BKPKM429.USD","SG9999014013.SGD","SG9999014021.USD","IE00B64PRP62.GBP","SG9999014005.SGD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00BN0W2W23.USD","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","BK4112","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642367892","title":"Pharvaris publishes patient-reported outcomes presentation on clinical evidence in HAE trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2642367892","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642367892?lang=en_us&edition=fundamental","pubTime":"2026-06-12 02:11","pubTimestamp":1781201476,"startTime":"0","endTime":"0","summary":"Pharvaris published a medical research presentation on patient-reported outcomes shaping clinical evidence in hereditary angioedema drug development.Slides flagged orphan-drug timelines: median FDA review 244 days; median development 7.2 years; median EMA review 353 days.RAPIDe-1 data showed deucrictibant immediate-release met the primary endpoint, reducing AMRA-3 attack symptoms at 4 hours versus placebo across 10 mg–30 mg doses.FDA feedback in the deck pointed to a global endpoint such as PGI-C as potentially more interpretable for primary outcomes.RAPIDe-3 was presented as a Phase 3 on-demand HAE trial design incorporating contemporaneous post-attack patient interviews to support endpoint selection.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDL7Ryz3B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHVS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642328653","title":"Pharvaris announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2642328653","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642328653?lang=en_us&edition=fundamental","pubTime":"2026-06-11 18:50","pubTimestamp":1781175015,"startTime":"0","endTime":"0","summary":"Pharvaris will hold its annual general meeting of shareholders in Zug, Switzerland on June 26, 2026.The meeting will cover the items set out in the notice and agenda to be posted in the company’s Investors section under Events & Presentations.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDL4wzyVj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","SG9999014039.USD","BK4585","LU2210149790.SGD","BK4112","SG9999014005.SGD","IE00B3QW5Z07.USD","BK4007","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","PHVS","NDAQ","SG9999014013.SGD","BK4588","IE00BN0W2W23.USD","IE00BKPKM429.USD","LU2095319765.USD","SG9999014021.USD","LU0314104364.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641176977","title":"A Look At Pharvaris (PHVS) Valuation As Deucrictibant Data Advances Toward Key EAACI 2026 Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2641176977","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641176977?lang=en_us&edition=fundamental","pubTime":"2026-06-07 21:28","pubTimestamp":1780838913,"startTime":"0","endTime":"0","summary":"Pharvaris (PHVS) is back in focus after announcing that eight deucrictibant abstracts, including Phase 3 and long term safety data, have been accepted for presentation at the 2026 European Academy of Allergy and Clinical Immunology Congress.\nSee our latest analysis for Pharvaris.\nAt a share price of US$31.09, Pharvaris has seen a 17.4% year to date share price return and an 85.3% total shareholder return over one year. The 1 day move was a modest pullback that contrasts with stronger 90 day...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/a-look-at-pharvaris-phvs-valuation-as-deucrictibant-data-adv","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/a-look-at-pharvaris-phvs-valuation-as-deucrictibant-data-adv","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PHVS","DCF","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639988168","title":"The Bull Case For Pharvaris (PHVS) Could Change Following New Deucrictibant Phase 3 Data Disclosures","url":"https://stock-news.laohu8.com/highlight/detail?id=2639988168","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639988168?lang=en_us&edition=fundamental","pubTime":"2026-05-31 21:12","pubTimestamp":1780233170,"startTime":"0","endTime":"0","summary":"Pharvaris recently announced that one oral presentation and seven flash talk/poster presentations on its oral HAE therapy deucrictibant were accepted for the European Academy of Allergy and Clinical Immunology Congress 2026, with materials to be shared via its investor website.\nThe update also confirms that Pharvaris is preparing marketing authorization filings for deucrictibant and progressing multiple Phase 3 programs, positioning the drug as a potentially comprehensive treatment option...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/the-bull-case-for-pharvaris-phvs-could-change-following-new","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/the-bull-case-for-pharvaris-phvs-could-change-following-new","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","PHVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639621901","title":"Pharvaris to present Phase 3 RAPIDe-3 end-of-progression data for oral deucrictibant in hereditary angioedema at EAACI 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2639621901","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639621901?lang=en_us&edition=fundamental","pubTime":"2026-05-29 18:51","pubTimestamp":1780051861,"startTime":"0","endTime":"0","summary":"Pharvaris flagged new Phase 3 RAPIDe-3 end-of-progression results for oral deucrictibant in on-demand hereditary angioedema attacks.Data will be presented at the EAACI Annual Congress 2026 in Istanbul on June 12-15, 2026.Additional EAACI presentations will cover cardiovascular safety, long-term prophylaxis experience, and a biomarker assay to distinguish angioedema types.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL41fhBM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHVS","BK4007","SG9999014021.USD","BK4112","LU2095319765.USD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00BN0W2V16.EUR","LU0314104364.USD","BK4588","IE00BN0W2T93.GBP","NDAQ","LU2210150020.SGD","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","BK4585","SG9999014039.USD","SG9999014013.SGD","IE00BKPKM429.USD","SG9999014005.SGD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638523061","title":"Pharvaris Principal Accounting Officer Anna Nijdam disposes of common shares worth $224,207.69","url":"https://stock-news.laohu8.com/highlight/detail?id=2638523061","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638523061?lang=en_us&edition=fundamental","pubTime":"2026-05-27 05:46","pubTimestamp":1779831970,"startTime":"0","endTime":"0","summary":"Pharvaris principal accounting officer Anna Nijdam exercised stock options on May 21-22 at USD 20, acquiring 7,330 shares.She sold 7,330 shares at weighted-average prices of USD 30.6 and USD 30.74, leaving her common stock stake unchanged at 48,945 shares.Her remaining stock options fell to 22,670 shares following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharvaris NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDLb47N51:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Pharvaris Principal Accounting Officer Anna Nijdam disposes of common shares worth $224,207.69","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHVS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":114,"code":"91000000","status":"200"}]}}